Therapy of advanced squamous carcinoma of the lung. Cyclophosphamide versus “COMB”
✍ Scribed by Gerald P. Bodey; Stephen W. Lagakos; Alberto C. Gutierrez; Henry E. Wilson; Oleg S. Selawry
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- English
- Weight
- 422 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
The four-drug combination of cyclophosphamide, vincristine, methyl CCNU and bleomycin was compared to CTX alone in a prospective randomized trial. Only one of 20 patients treated with COMB and one of 27 patients treated with CTX achieved a partial response. CTX was associated with a significantly better survival than COMB among patients who were ambulatory at onset of therapy. Survival among non-ambulatory patients was similar with both regimens.
Cancer 39
📜 SIMILAR VOLUMES
## Abstract ## Background. Our aim was to review our experience in the management of advanced tonsillar squamous cell carcinoma (SCC) and to compare treatment outcomes between patients treated with and without surgery to the primary site. ## Methods. The records of 74 patients with advanced‐stag